Revolution Medicines $RVMD **UOA** surged 30.66% after a potential cancer drug, daraxonrasib, helped patients with advanced pancreatic cancer live longer. @petenajarian @jonnajarian #ITSNOTANOPTION 📙 https://t.co/6oURR2iuaJ
@MarketRebels
STARTS NOW Rebels Edge 1pm $RVMD $GS $FAST $BBY 🏈 NAJARIAN SPORTS 🏴☠️ with @petenajarian GOLF: Masters, Mcilroy was on fire Rory 2nd round was epic, he lead after every round NFL: Draft in 10 days 3 players that are moving up: Freeling, Thineman, Gentry #ITSNOTANOPTION 📙 https://t.co/UqitZZUz62
@MarketRebels
Revolution Medicines plummets on report Merck walks from acquisition talks
SeekingAlpha
Revolution Medicines declines to comment on M&A speculation at conference
SeekingAlpha
Merck in talks to acquire Revolution Medicines for about $30B - WSJ
SeekingAlpha
Revolution Medicines soars on report Merck in talks to buy
SeekingAlpha
AbbVie says not in talks to buy Revolution Medicines - report
SeekingAlpha
Revolution Medicines jumps on report AbbVie nears takeover
SeekingAlpha
Last week, our Heatseeker algorithm picked up #UnusualActivity in $RVMD puts.
This morning, it's down almost 43%! BANG! https://t.co/OfLIdK4SDO
@MarketRebels
Revolution Medicines will buy EQRx in an all-stock transaction